Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Lidocaine in Elderly Colorectal Cancer Surgery
NCT06405776Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in colorectal cancer (CRC) comparing Lidocaine Group with Placebo Group (2 arms). Primary endpoint: The incidence of chronic pain at 3 months. Started Jun 2023; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06405776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06405776.